These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 35984862)
1. Systemic RNA Interference Defective (SID) genes modulate dopaminergic neurodegeneration in C. elegans. Gaeta AL; Nourse JB; Willicott K; McKay LE; Keogh CM; Peter K; Russell SN; Hamamichi S; Berkowitz LA; Caldwell KA; Caldwell GA PLoS Genet; 2022 Aug; 18(8):e1010115. PubMed ID: 35984862 [TBL] [Abstract][Full Text] [Related]
2. Integrated regulation of dopaminergic and epigenetic effectors of neuroprotection in Parkinson's disease models. Nourse JB; Russell SN; Moniz NA; Peter K; Seyfarth LM; Scott M; Park HA; Caldwell KA; Caldwell GA Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2210712120. PubMed ID: 36745808 [TBL] [Abstract][Full Text] [Related]
3. Valproic acid ameliorates C. elegans dopaminergic neurodegeneration with implications for ERK-MAPK signaling. Kautu BB; Carrasquilla A; Hicks ML; Caldwell KA; Caldwell GA Neurosci Lett; 2013 Apr; 541():116-9. PubMed ID: 23485787 [TBL] [Abstract][Full Text] [Related]
4. Tissue-specific overexpression of systemic RNA interference components limits lifespan in C. elegans. Camara H; Inan MD; Vergani-Junior CA; Pinto S; Knittel TL; Salgueiro WG; Tonon-da-Silva G; Ramirez J; de Moraes D; Braga DL; De-Souza EA; Mori MA Gene; 2024 Feb; 895():148014. PubMed ID: 37984536 [TBL] [Abstract][Full Text] [Related]
5. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes. Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512 [TBL] [Abstract][Full Text] [Related]
6. RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans. Kaur S; Sammi SR; Jadiya P; Nazir A CNS Neurol Disord Drug Targets; 2012 Jun; 11(4):387-94. PubMed ID: 22483307 [TBL] [Abstract][Full Text] [Related]
7. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease. Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384 [TBL] [Abstract][Full Text] [Related]
8. Regulation of TIR-1/SARM-1 by miR-71 Protects Dopaminergic Neurons in a Naidoo D; de Lencastre A Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201481 [TBL] [Abstract][Full Text] [Related]
9. SID-4/NCK-1 is important for dsRNA import in Caenorhabditis elegans. Bhatia S; Hunter CP G3 (Bethesda); 2022 Nov; 12(11):. PubMed ID: 36165710 [TBL] [Abstract][Full Text] [Related]
10. Caenorhabditis elegans as a model system for identifying effectors of α-synuclein misfolding and dopaminergic cell death associated with Parkinson's disease. Harrington AJ; Knight AL; Caldwell GA; Caldwell KA Methods; 2011 Mar; 53(3):220-5. PubMed ID: 21195766 [TBL] [Abstract][Full Text] [Related]
11. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans. Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson's disease. Harrington AJ; Yacoubian TA; Slone SR; Caldwell KA; Caldwell GA J Neurosci; 2012 Feb; 32(6):2142-53. PubMed ID: 22323726 [TBL] [Abstract][Full Text] [Related]
13. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease. Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494 [TBL] [Abstract][Full Text] [Related]
14. Export of RNA silencing from C. elegans tissues does not require the RNA channel SID-1. Jose AM; Smith JJ; Hunter CP Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2283-8. PubMed ID: 19168628 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model. Ray A; Martinez BA; Berkowitz LA; Caldwell GA; Caldwell KA Cell Death Dis; 2014 Jan; 5(1):e984. PubMed ID: 24407237 [TBL] [Abstract][Full Text] [Related]
16. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans. Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053 [TBL] [Abstract][Full Text] [Related]
17. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans. Jadiya P; Fatima S; Baghel T; Mir SS; Nazir A Mol Neurobiol; 2016 Nov; 53(9):6288-6300. PubMed ID: 26567108 [TBL] [Abstract][Full Text] [Related]
18. Enhanced neuronal RNAi in C. elegans using SID-1. Calixto A; Chelur D; Topalidou I; Chen X; Chalfie M Nat Methods; 2010 Jul; 7(7):554-9. PubMed ID: 20512143 [TBL] [Abstract][Full Text] [Related]
19. SID-1 Functions in Multiple Roles To Support Parental RNAi in Wang E; Hunter CP Genetics; 2017 Oct; 207(2):547-557. PubMed ID: 28751423 [TBL] [Abstract][Full Text] [Related]